BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37155185)

  • 1. Cancer detection and complications of transperineal prostate biopsy with antibiotics when indicated.
    Boevé LMS; Bloemendal FT; de Bie KCC; van Haarst EP; Krul EJT; de Bruijn JJ; Beems S; Vanhommerig JW; Hovius MC; Ruiter AEC; Lagerveld BW; van Andel G
    BJU Int; 2023 Oct; 132(4):397-403. PubMed ID: 37155185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: Cancer detection rates and complication rates.
    Hogenhout R; Remmers S; van Leenders GJLH; Roobol MJ
    Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):581-587. PubMed ID: 36631536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the optimal strategy in men with a single unilateral suspicious lesion on MRI undergoing transperineal MRI/ultrasound fusion prostate biopsy.
    Yusim I; Mazor E; Frumkin E; Jabareen M; Hefer B; Elsaraya N; Li S; Rouvinov K; Novack V; Mabjeesh NJ
    Prostate; 2023 Sep; 83(13):1255-1262. PubMed ID: 37263774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance Imaging/Ultrasound Fusion-guided Transperineal Versus Magnetic Resonance Imaging/Ultrasound Fusion-guided Transrectal Prostate Biopsy-A Systematic Review.
    Rai BP; Mayerhofer C; Somani BK; Kallidonis P; Nagele U; Tokas T
    Eur Urol Oncol; 2021 Dec; 4(6):904-913. PubMed ID: 33478936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.
    Kaufmann B; Saba K; Schmidli TS; Stutz S; Bissig L; Britschgi AJ; Schaeren E; Gu A; Langenegger N; Sulser T; Eberli D; Keller EX; Hermanns T; Poyet C
    Prostate; 2022 Feb; 82(3):388-396. PubMed ID: 34914121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance-Ultrasound Fusion Guided Biopsy Using Local Anesthesia.
    Immerzeel J; Israël B; Bomers J; Schoots IG; van Basten JP; Kurth KH; de Reijke T; Sedelaar M; Debruyne F; Barentsz J
    Eur Urol; 2022 Jan; 81(1):110-117. PubMed ID: 34799197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
    van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
    Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transperineal freehand multiparametric MRI fusion targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicentre prospective study of 1014 cases.
    Marra G; Zhuang J; Beltrami M; Calleris G; Zhao X; Marquis A; Kan Y; Oderda M; Huang H; Faletti R; Zhang Q; Molinaro L; Wang W; Bergamasco L; Guo H; Gontero P
    BJU Int; 2021 Jan; 127(1):122-130. PubMed ID: 32455504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is targeted magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy enough for the detection of prostate cancer in patients with PI-RADS ≥3: Results of a prospective, randomized clinical trial.
    Zhang J; Zhu A; Sun D; Guo S; Zhang H; Liu S; Fu Q; Zhang K
    J Cancer Res Ther; 2020; 16(7):1698-1702. PubMed ID: 33565519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
    Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
    Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.
    Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F
    Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiparametric MRI-ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic-assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy.
    Lee AYM; Yang XY; Lee HJ; Law YM; Huang HH; Lau WKO; Lee LS; Ho HSS; Tay KJ; Cheng CWS; Yuen JSP; Chen K
    BJU Int; 2020 Nov; 126(5):568-576. PubMed ID: 32438463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transperineal prostate biopsy with cognitive magnetic resonance imaging/biplanar ultrasound fusion: description of technique and early results.
    Gorin MA; Meyer AR; Zimmerman M; Harb R; Joice GA; Schwen ZR; Allaf ME
    World J Urol; 2020 Aug; 38(8):1943-1949. PubMed ID: 31679065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic versus Targeted Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy among Men with Visible Lesions.
    Patel HD; Koehne EL; Shea SM; Fang AM; Gorbonos A; Quek ML; Flanigan RC; Goldberg A; Rais-Bahrami S; Gupta GN
    J Urol; 2022 Jan; 207(1):108-117. PubMed ID: 34428091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter transperineal MRI-TRUS fusion guided outpatient clinic prostate biopsies under local anesthesia.
    Jacewicz M; Günzel K; Rud E; Lauritzen PM; Galtung KF; Hinz S; Magheli A; Baco E
    Urol Oncol; 2021 Jul; 39(7):432.e1-432.e7. PubMed ID: 33257219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique.
    Bryant RJ; Yamamoto H; Eddy B; Kommu S; Narahari K; Omer A; Leslie T; Catto JWF; Rosario DJ; Good DW; Gray R; Liew MPC; Lopez JF; Campbell T; Reynard JM; Tuck S; Barber VS; Medeghri N; Davies L; Parkes M; Hewitt A; Landeiro F; Wolstenholme J; Macpherson R; Verrill C; Marian IR; Williams R; Hamdy FC; Lamb AD
    BJU Int; 2023 Jun; 131(6):694-704. PubMed ID: 36695816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of prostate cancer detection rates in patients undergoing MRI/TRUS fusion prostate biopsy with two different software-based systems.
    Hanske J; Risse Y; Roghmann F; Pucheril D; Berg S; Tully KH; von Landenberg N; Wald J; Noldus J; Brock M
    Prostate; 2022 Feb; 82(2):227-234. PubMed ID: 34734428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection rate and complications after 621 transperineal MRI-TRUS fusion biopsies in local anesthesia without standard antibiotic prophylaxis.
    Günzel K; Magheli A; Baco E; Cash H; Heinrich S; Neubert H; Schlegel J; Schostak M; Henkel T; Asbach P; Hinz S
    World J Urol; 2021 Oct; 39(10):3861-3866. PubMed ID: 33866401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective Comparison of Transrectal Standard, Cognitive, Transperineal Fusion, and Mapping Prostate Biopsy for Cancer Detection.
    Petov V; Bazarkin A; Morozov A; Taratkin M; Ganzha T; Danilov S; Chernov Y; Chinenov D; Rzayev R; Suvorov A; Amosov A; Fajkovic H; Enikeev D; Krupinov G
    J Endourol; 2023 Aug; 37(8):940-947. PubMed ID: 37294206
    [No Abstract]   [Full Text] [Related]  

  • 20. Initial experience of magnetic resonance imaging/ultrasonography fusion transperineal biopsy: Biopsy techniques and results for 75 patients.
    Tae JH; Shim JS; Jin HJ; Yoon SG; No TI; Kim JY; Kang SH; Cheon J; Kang SG
    Investig Clin Urol; 2018 Nov; 59(6):363-370. PubMed ID: 30402568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.